Caisse Des Depots ET Consignations bought a new position in shares of MetLife, Inc. (NYSE:MET - Free Report) in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor bought 22,373 shares of the financial services provider's stock, valued at approximately $1,832,000.
A number of other hedge funds have also modified their holdings of MET. Bank of New York Mellon Corp raised its holdings in MetLife by 109.2% in the 4th quarter. Bank of New York Mellon Corp now owns 8,826,658 shares of the financial services provider's stock valued at $722,727,000 after acquiring an additional 4,606,748 shares during the last quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC increased its holdings in shares of MetLife by 1.5% in the third quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 4,548,725 shares of the financial services provider's stock valued at $375,179,000 after purchasing an additional 68,579 shares during the last quarter. Nordea Investment Management AB lifted its position in MetLife by 16.8% during the fourth quarter. Nordea Investment Management AB now owns 4,238,087 shares of the financial services provider's stock worth $347,735,000 after buying an additional 608,224 shares in the last quarter. Charles Schwab Investment Management Inc. boosted its stake in MetLife by 0.8% during the fourth quarter. Charles Schwab Investment Management Inc. now owns 3,913,408 shares of the financial services provider's stock worth $320,430,000 after buying an additional 30,187 shares during the last quarter. Finally, Swedbank AB grew its holdings in MetLife by 76.0% in the 4th quarter. Swedbank AB now owns 3,466,808 shares of the financial services provider's stock valued at $283,862,000 after buying an additional 1,496,645 shares in the last quarter. 94.99% of the stock is currently owned by institutional investors and hedge funds.
Analyst Upgrades and Downgrades
Several research analysts have recently commented on the company. BMO Capital Markets assumed coverage on MetLife in a report on Thursday, January 23rd. They set a "market perform" rating and a $97.00 price target on the stock. StockNews.com cut shares of MetLife from a "buy" rating to a "hold" rating in a research note on Thursday, January 9th. JPMorgan Chase & Co. lifted their price target on shares of MetLife from $86.00 to $88.00 and gave the company an "overweight" rating in a research report on Tuesday, January 7th. Wells Fargo & Company increased their price objective on MetLife from $92.00 to $97.00 and gave the stock an "overweight" rating in a research report on Wednesday, February 19th. Finally, Morgan Stanley lifted their target price on MetLife from $101.00 to $109.00 and gave the company an "overweight" rating in a research report on Friday, February 28th. Two research analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the stock. According to data from MarketBeat, MetLife has a consensus rating of "Moderate Buy" and a consensus target price of $94.58.
Read Our Latest Stock Analysis on MET
MetLife Stock Up 1.2 %
Shares of MET traded up $0.96 during mid-day trading on Tuesday, hitting $81.25. 804,368 shares of the company's stock were exchanged, compared to its average volume of 3,540,361. The company has a debt-to-equity ratio of 0.54, a quick ratio of 0.16 and a current ratio of 0.16. The company has a market cap of $55.35 billion, a price-to-earnings ratio of 13.61, a P/E/G ratio of 0.65 and a beta of 1.04. The stock's 50-day moving average is $83.16 and its 200-day moving average is $82.98. MetLife, Inc. has a fifty-two week low of $67.30 and a fifty-two week high of $89.05.
MetLife (NYSE:MET - Get Free Report) last issued its quarterly earnings results on Wednesday, February 5th. The financial services provider reported $2.08 EPS for the quarter, missing the consensus estimate of $2.13 by ($0.05). MetLife had a net margin of 6.19% and a return on equity of 20.42%. On average, sell-side analysts anticipate that MetLife, Inc. will post 9.65 earnings per share for the current fiscal year.
MetLife Announces Dividend
The business also recently disclosed a quarterly dividend, which was paid on Tuesday, March 11th. Stockholders of record on Tuesday, February 4th were paid a $0.545 dividend. This represents a $2.18 annualized dividend and a dividend yield of 2.68%. The ex-dividend date was Tuesday, February 4th. MetLife's payout ratio is presently 36.52%.
About MetLife
(
Free Report)
MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.
Featured Articles

Before you consider MetLife, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and MetLife wasn't on the list.
While MetLife currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.